Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0083 Transporter Info
Gene Name	SLC12A2
Transporter Name	Basolateral Na-K-Cl symporter
Gene ID	6558
UniProt ID	P55011

Post-Translational Modification of This DT
Overview of SLC12A2 Modification Sites with Functional and Structural Information
Sequence	M E P R P T A P S S G A P G L A G V G E T P S A A A L A A A R V E L P G T A V P S V P E D A A P A S R D G G G V R D E G P A A A G D G L G R P L G P T P S Q S R F Q V D L V S E N A G R A A A A A A A A A A A A A A A G A G A G A K Q T P A D G E A S G E S E P A K G S E E A K G R F R V N F V D P A A S S S A E D S L S D A A G V G V D G P N V S F Q N G G D T V L S E G S S L H S G G G G G S G H H Q H Y Y Y D T H T N T Y Y L R T F G H N T M D A V P R I D H Y R H T A A Q L G E K L L R P S L A E L H D E L E K E P F E D G F A N G E E S T P T R D A V V T Y T A E S K G V V K F G W I K G V L V R C M L N I W G V M L F I R L S W I V G Q A G I G L S V L V I M M A T V V T T I T G L S T S A I A T N G F V R G G G A Y Y L I S R S L G P E F G G A I G L I F A F A N A V A V A M Y V V G F A E T V V E L L K E H S I L M I D E I N D I R I I G A I T V V I L L G I S V A G M E W E A K A Q I V L L V I L L L A I G D F V I G T F I P L E S K K P K G F F G Y K S E I F N E N F G P D F R E E E T F F S V F A I F F P A A T G I L A G A N I S G D L A D P Q S A I P K G T L L A I L I T T L V Y V G I A V S V G S C V V R D A T G N V N D T I V T E L T N C T S A A C K L N F D F S S C E S S P C S Y G L M N N F Q V M S M V S G F T P L I S A G I F S A T L S S A L A S L V S A P K I F Q A L C K D N I Y P A F Q M F A K G Y G K N N E P L R G Y I L T F L I A L G F I L I A E L N V I A P I I S N F F L A S Y A L I N F S V F H A S L A K S P G W R P A F K Y Y N M W I S L L G A I L C C I V M F V I N W W A A L L T Y V I V L G L Y I Y V T Y K K P D V N W G S S T Q A L T Y L N A L Q H S I R L S G V E D H V K N F R P Q C L V M T G A P N S R P A L L H L V H D F T K N V G L M I C G H V H M G P R R Q A M K E M S I D Q A K Y Q R W L I K N K M K A F Y A P V H A D D L R E G A Q Y L M Q A A G L G R M K P N T L V L G F K K D W L Q A D M R D V D M Y I N L F H D A F D I Q Y G V V V I R L K E G L D I S H L Q G Q E E L L S S Q E K S P G T K D V V V S V E Y S K K S D L D T S K P L S E K P I T H K V E E E D G K T A T Q P L L K K E S K G P I V P L N V A D Q K L L E A S T Q F Q K K Q G K N T I D V W W L F D D G G L T L L I P Y L L T T K K K W K D C K I R V F I G G K I N R I D H D R R A M A T L L S K F R I D F S D I M V L G D I N T K P K K E N I I A F E E I I E P Y R L H E D D K E Q D I A D K M K E D E P W R I T D N E L E L Y K T K T Y R Q I R L N E L L K E H S S T A N I I V M S L P V A R K G A V S S A L Y M A W L E A L S K D L P P I L L V R G N H Q S V L T F Y S
PTM type	X-Acetylation X-Malonylation X-Methylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[1]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC12A2 Methionine 1 has the potential to affect its expression or activity.
Malonylation
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	852
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC12A2 Lysine 852 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1061
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC12A2 Lysine 1061 has the potential to affect its expression or activity.
Methylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	833
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC12A2 Lysine 833 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	630
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC12A2 Cystine 630 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	820
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC12A2 Cystine 820 has the potential to affect its expression or activity.
Phosphorylation
Serine	27 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 23 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A2			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	41
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 41 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A2			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	50
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 50 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A2			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	77
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 77 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A2			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 79 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A2			[8] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 87 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A2			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 123 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A2			[8] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	126
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 126 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A2			[7] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	132
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 132 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A2			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	242
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 242 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A2			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	265
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 265 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 279 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	399
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 399 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	424
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 424 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A2			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	836
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 836 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A2			[15] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	929
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 929 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC12A2			[9] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	939
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 939 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC12A2			[9] , [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	940
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 940 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC12A2			[7] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	944
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 944 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC12A2			[8] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	953
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 953 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC12A2			[19] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	957
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 957 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC12A2			[11] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	965
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 965 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC12A2			[10] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	994
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 994 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SLC12A2			[25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1012
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 1012 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SLC12A2			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1077
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 1077 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SLC12A2			[8] , [26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Serine 1212 has the potential to affect its expression or activity.
Threonine	20 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[27] , [28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 21 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[18] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	75
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 75 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A2			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	116
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 116 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A2			[30] , [31]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 203 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A2			[30] , [31]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	207
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 207 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A2			[18] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 212 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A2			[12] , [23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 217 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A2			[7] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	230
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 230 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A2			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 266 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A2			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 268 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A2			[19] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	274
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 274 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	276
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 276 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A2			[15] , [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	947
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 947 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A2			[11] , [33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	964
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 964 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A2			[34] , [35]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	984
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 984 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A2			[34] , [35]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	986
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 986 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A2			[25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1013
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 1013 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC12A2			[25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1074
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 1074 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC12A2			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1144
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 1144 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC12A2			[36]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1146
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Threonine 1146 has the potential to affect its expression or activity.
Tyrosine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A2			[37]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	208
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 208 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[38] , [39]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 227 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A2			[19] , [40]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	275
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 275 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A2			[41]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	711
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 711 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A2			[21]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	842
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 842 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A2			[42]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	855
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 855 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A2			[24] , [43]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	956
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 956 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A2			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1142
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 1142 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A2			[36]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 1147 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A2			[25] , [39]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1211
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A2 Tyrosine 1211 has the potential to affect its expression or activity.
Ubiquitination
Lysine	24 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC12A2			[44]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	1017
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1017 have been reported to decrease its cell surface expression.
PTM Phenomenon 2	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	114
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 114 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 130 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	237
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 237 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 252 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	280
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 280 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	923
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 923 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	943
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 943 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	948
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 948 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	958
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 958 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	959
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 959 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	966
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 966 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	971
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 971 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	976
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 976 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	983
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 983 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	991
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 991 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	995
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 995 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1007
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1007 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1061
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1061 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1095
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1095 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1098
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1098 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1118
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1118 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1125
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1125 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC12A2			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1143
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A2 Lysine 1143 has the potential to affect its expression or activity.

References
1	Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-alpha-acetylation features. Mol Cell Proteomics. 2012 Jun;11(6):M111.015131.
2	Integration of A Deep Learning Classifier with A Random Forest Approach for Predicting Malonylation Sites. Genomics Proteomics Bioinformatics. 2018 Dec;16(6):451-459.
3	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S12A2_HUMAN)
5	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
6	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7	Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. Mol Biol Cell. 2018 May 1;29(9):1031-1047.
8	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
9	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
10	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
11	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
12	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
13	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
14	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
15	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
16	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
17	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
18	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
19	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
20	Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 6;6(30):29143-60.
21	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
22	Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
23	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
24	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
25	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
26	Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics. Mol Cell Proteomics. 2016 Jul;15(7):2448-61.
27	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
28	Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
29	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
30	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
31	SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation. Biochem J. 2012 Jan 1;441(1):325-37.
32	Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions. Mol Cell Proteomics. 2017 May;16(5):855-872.
33	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
34	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
35	Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics. 2014 Jan;13(1):311-28.
36	Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017 Feb 3;16(2):538-549.
37	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
38	Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017 Jan 12;129(2):e1-e12.
39	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
40	Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms. Proteomics. 2016 Jul;16(14):1998-2004.
41	Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
42	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
43	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
44	Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci. 2021 Apr 17;11(1):75.
45	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
46	Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin. J Proteome Res. 2012 Feb 3;11(2):796-807.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence